BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36224027)

  • 1. Exosomal miR-22-3p from Mesenchymal Stem Cells Inhibits the Epithelial-Mesenchymal Transition (EMT) of Melanoma Cells by Regulating
    Chen Y; Fang Y; Li L; Luo H; Cao T; Tu B
    Front Biosci (Landmark Ed); 2022 Sep; 27(9):275. PubMed ID: 36224027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-3p targets SOCS1 to facilitate progression of esophageal cancer.
    Deng Y; Julaiti A; Ran W; He Y
    Life Sci; 2021 Aug; 278():119491. PubMed ID: 33862112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial-mesenchymal transition through targeting EphA4.
    Luan W; Ding Y; Xi H; Ruan H; Lu F; Ma S; Wang J
    J Exp Clin Cancer Res; 2021 Mar; 40(1):107. PubMed ID: 33741023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse mesenchymal stem cell-derived exosomal miR-466f-3p reverses EMT process through inhibiting AKT/GSK3β pathway via c-MET in radiation-induced lung injury.
    Li Y; Shen Z; Jiang X; Wang Y; Yang Z; Mao Y; Wu Z; Li G; Chen H
    J Exp Clin Cancer Res; 2022 Apr; 41(1):128. PubMed ID: 35392967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3.
    Yi X; Wei X; Lv H; An Y; Li L; Lu P; Yang Y; Zhang Q; Yi H; Chen G
    Exp Cell Res; 2019 Oct; 383(2):111454. PubMed ID: 31170401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B.
    Zhang F; Lu Y; Wang M; Zhu J; Li J; Zhang P; Yuan Y; Zhu F
    Mol Cell Probes; 2020 Jun; 51():101513. PubMed ID: 31968218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial-mesenchymal transition and angiogenesis in triple-negative breast cancer cells.
    Shojaei S; Moradi-Chaleshtori M; Paryan M; Koochaki A; Sharifi K; Mohammadi-Yeganeh S
    Eur J Med Res; 2023 Nov; 28(1):516. PubMed ID: 37968694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulated HDAC3 elevates microRNA-495-3p to restrain epithelial-mesenchymal transition and oncogenicity of melanoma cells via reducing TRAF5.
    Ma Y; Duan J; Hao X
    J Cell Mol Med; 2020 Nov; 24(22):12933-12944. PubMed ID: 33048450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMSCs-Derived Exosomal MiR-126-3p Inhibits the Viability of NSCLC Cells by Targeting PTPN9.
    Chen J; Ding C; Yang X; Zhao J
    J BUON; 2021; 26(5):1832-1841. PubMed ID: 34761590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes Released from Bone-Marrow Stem Cells Ameliorate Hippocampal Neuronal Injury Through transferring miR-455-3p.
    Gan C; Ouyang F
    J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106142. PubMed ID: 35598413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human placenta mesenchymal stem cell-derived exosome shuttling microRNA-130b-3p from gestational diabetes mellitus patients targets ICAM-1 and perturbs human umbilical vein endothelial cell angiogenesis.
    Gao Z; Wang N; Liu X
    Acta Diabetol; 2022 Aug; 59(8):1091-1107. PubMed ID: 35676597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial-mesenchymal transition by targeting HOXC6.
    Li D; Zhang J; Liu Z; Gong Y; Zheng Z
    Stem Cell Res Ther; 2021 Jan; 12(1):24. PubMed ID: 33413548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes from Human Umbilical Cord Mesenchymal Stem Cells Facilitates Injured Endometrial Restoring in Early Repair Period through miR-202-3p Mediating Formation of ECM.
    Wang S; Liu T; Nan N; Lu C; Liang M; Wang S; Wang H; He B; Chen X; Xu X; Zheng Y
    Stem Cell Rev Rep; 2023 Aug; 19(6):1954-1964. PubMed ID: 37226011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mesenchymal stem cell derived exosomes inhibit the survival of human melanoma cells through modulating miR-138-5p/SOX4 pathway.
    Wang X; Cui Z; Zeng B; Qiong Z; Long Z
    Cancer Biomark; 2022; 34(4):533-543. PubMed ID: 35275523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-203a-3p Inhibits Pancreatic Cancer Cell Proliferation, EMT, and Apoptosis by Regulating SLUG.
    An N; Zheng B
    Technol Cancer Res Treat; 2020; 19():1533033819898729. PubMed ID: 32301392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-223-3p overexpressed adipose mesenchymal stem cell-derived exosomes promote wound healing via targeting MAPK10.
    Liu X; Jin S; Liu J; Xu X
    Acta Histochem; 2023 Dec; 125(8):152102. PubMed ID: 37837832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow stromal cells derived exosomal miR-10a and miR-16 may be involved in progression of patients with multiple myeloma by regulating EPHA8 or IGF1R/CCND1.
    Peng Y; Song X; Lan J; Wang X; Wang M
    Medicine (Baltimore); 2021 Jan; 100(4):e23447. PubMed ID: 33530159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.